[ Price : $8.95]
FDA issues a draft guidance entitled Considerations for the Use of the Plausible Mechanism Framework to Develop Individualized The...[ Price : $8.95]
FDA approves AstraZenecas Calquence (acalabrutinib) for use in combination with AbbVie and Genentechs Venclexta (venetoclax), a ch...[ Price : $8.95]
Novo Nordisk says its experimental obesity drug CagriSema delivered substantial weight loss in a head-to-head late-stage trial but...[ Price : $8.95]
FDA appointed a veteran artificial intelligence executive to lead its digital health policy unit, signaling a sharper regulatory f...[ Price : $8.95]
A Mintz legal update says FDA appears to be sustaining and in some cases accelerating its scrutiny of prescription drug advertis...[ Price : $8.95]
Olympus recalls its high-flow insufflation units, warning that continued use of the devices could cause serious injury or death.[ Price : $8.95]
FDA places a partial clinical hold on a MacroGenics Phase 2 (LINNET) trial of its investigational immunotherapy lorigerlimab after...[ Price : $8.95]
Attorney Grant Hollingsworth outlines Trump administration changes that could positively or negatively affect a preemption defense...